z-logo
open-access-imgOpen Access
HTLV-1 Tax-Mediated Inhibition of FOXO3a Activity Is Critical for the Persistence of Terminally Differentiated CD4+ T Cells
Author(s) -
David Olagnier,
Alexandre Sze,
Samar Bel Hadj,
Cindy Chiang,
Courtney Steel,
Xiaoying Han,
JeanPierre Routy,
Rongtuan Lin,
John Hiscott,
Julien van Grevenynghe
Publication year - 2014
Publication title -
plos pathogens
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.719
H-Index - 206
eISSN - 1553-7374
pISSN - 1553-7366
DOI - 10.1371/journal.ppat.1004575
Subject(s) - protein kinase b , phosphorylation , gene silencing , biology , small interfering rna , transcription factor , microbiology and biotechnology , cancer research , rna , genetics , gene
The mechanisms involved in the persistence of activated CD4 + T lymphocytes following primary human T leukemia/lymphoma virus type 1 (HTLV-1) infection remain unclear. Here, we demonstrate that the HTLV-1 Tax oncoprotein modulates phosphorylation and transcriptional activity of the FOXO3a transcription factor, via upstream activation of the AKT pathway. De novo HTLV-1 infection of CD4 + T cells or direct lentiviral-mediated introduction of Tax led to AKT activation and AKT-dependent inactivation of FOXO3a, via phosphorylation of residues Ser253 and Thr32. Inhibition of FOXO3a signalling led to the long-term survival of a population of highly activated, terminally differentiated CD4 + Tax + CD27 neg CCR7 neg T cells that maintained the capacity to disseminate infectious HTLV-1. CD4 + T cell persistence was reversed by chemical inhibition of AKT activity, lentiviral-mediated expression of a dominant-negative form of FOXO3a or by specific small interfering RNA (siRNA)-mediated silencing of FOXO3a. Overall this study provides new mechanistic insight into the strategies used by HTLV-1 to increase long-term maintenance of Tax + CD4 + T lymphocytes during the early stages of HTLV-1 pathogenesis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom